Midodrine
Midodrine is an oral tablet medicine used to treat symptomatic orthostatic hypotension, a drop in blood pressure on standing that causes symptoms like dizziness.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 52 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Midodrine treats symptomatic orthostatic hypotension (blood pressure that drops when you stand, causing dizziness) by tightening small arteries and veins. On the market since about 1996 and available generically, it is a main option once support stockings, fluids and lifestyle changes fall short. Most people tolerate it reasonably well, though scalp tingling or itching, goosebumps and needing to urinate more often are common. The boxed warning is markedly high blood pressure when lying down, so take it only during upright daytime hours, report a pounding headache or blurred vision, keep up with lying-down blood pressure checks, and continue it only if it clearly helps.
Clinical pearls
- Take the last dose by early evening, well before bedtime, so it is not still raising your pressure once you lie down.
- Skip cold and sinus products containing pseudoephedrine or phenylephrine, which add to midodrine and can push blood pressure dangerously high.
- If you also take fludrocortisone or salt tablets, expect closer lying-down blood pressure checks, since together they raise that risk.
- Tell your prescriber if you take digoxin, because the combination can slow the heartbeat or disturb its rhythm.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Midodrine can cause a marked rise in blood pressure when you are lying down. Because of this, it is for people whose lives are considerably impaired despite standard care.
It was approved based on its ability to raise standing blood pressure. Its clinical benefit, mainly an improved ability to carry out daily activities, has not been verified. Your doctor should watch your blood pressure, and you should report any severe headache, blurred vision or pounding in the head.
Patient information guide A plain-language walkthrough of Midodrine, written from its FDA label.
What Midodrine is used for
▾
Midodrine tablets have one supported use.
- Symptomatic orthostatic hypotension, a drop in blood pressure on standing that causes symptoms. This applies to Midodrine Hydrochloride and Midodrine HCl oral tablets.
- It is for people considerably impaired despite standard care such as support stockings, fluid expansion and lifestyle changes.
How Midodrine works
▾
Midodrine is a prodrug. Your body turns it into desglymidodrine, which activates alpha-1 receptors on the small arteries and veins. This tightens the blood vessels and raises blood pressure.
It does not stimulate the heart's beta receptors, and it does not enter the brain easily. It has no significant effect on pulse rate in people with autonomic failure.
Midodrine dosage
▾
Midodrine tablets are taken by mouth, usually three times daily during the daytime when you need to be upright.
- Doses are spaced about 4 hours apart, or 3 hours if needed for symptoms, but not closer.
- Take the last dose no later than 6 P.M., and not within 4 hours of bedtime.
- Food does not affect how much active drug your body gets.
Follow your prescriber's instructions and the label.
Dosing details from the FDA-approved label
From the Midodrine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Symptomatic orthostatic hypotension (general recommended dosing)
- 10 mg, 3 times daily, during the daytime hours when the patient needs to be upright
- Suggested schedule at approximately 4-hour intervals: shortly before or upon arising in the morning, midday and late afternoon (not later than 6 P.M.)
- Doses may be given in 3-hour intervals, if required, to control symptoms, but not more frequently
- Maximum: Single doses as high as 20 mg have been given, but severe and persistent systolic supine hypertension occurs at a high rate (about 45%) at this dose. Total daily doses greater than 30 mg have been tolerated by some patients, but safety and usefulness have not been studied systematically or established.
- Should not be given after the evening meal or less than 4 hours before bedtime; continue only in patients who attain symptomatic improvement during initial treatment.
- Patients with abnormal renal function
- Initiate treatment using 2.5 mg doses
- Dosing should be cautious because desglymidodrine is excreted renally; not systematically studied.
- Children
- Dosing in children has not been adequately studied
- Patients 65 or older vs. younger than 65, and males vs. females
- Dose modifications are not necessary
- Blood levels of midodrine and desglymidodrine were similar between these groups.
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION The recommended dose of midodrine hydrochloride tablets is 10 mg, 3 times daily. Dosing should take place during the daytime hours when the patient needs to be upright, pursuing the activities of daily living. A suggested dosing schedule of approximately 4-hour intervals is as follows: shortly before, or upon arising in the morning, midday and late afternoon (not later than 6 P.M.). Doses may be given in 3-hour intervals, if required, to control symptoms, but not more frequently. Single doses as high as 20 mg have been given to patients, but severe and persistent systolic supine hypertension occurs at a high rate (about 45%) at this dose. In order to reduce the potential for supine hypertension during sleep, midodrine hydrochloride tablets should not be given after the evening meal or less than 4 hours before bedtime. Total daily doses greater than 30 mg have been tolerated by some patients, but their safety and usefulness have not been studied systematically or established. Because of the risk of supine hypertension, midodrine hydrochloride tablets should be continued only in patients who appear to attain symptomatic improvement during initial treatment. The supine and standing blood pressure should be monitored regularly, and the administration of midodrine hydrochloride tablets should be stopped if supine blood pressure increases excessively. Because desglymidodrine is excreted renally, dosing in patients with abnormal renal function should be cautious; although this has not been systematically studied, it is recommended that treatment of these patients be initiated using 2.5 mg doses. Dosing in children has not been adequately studied. Blood levels of midodrine and desglymidodrine were similar when comparing levels in patients 65 or older vs. younger than 65 and when comparing males vs. females, suggesting dose modifications for these groups are not necessary.
Read the full Dosage and Administration section on DailyMed →
Midodrine side effects
▾
Most side effects come from midodrine acting on receptors in the skin, hair follicles and bladder.
Common side effects
- Tingling or “pins and needles” feeling, mainly on the scalp
- Itching, mainly on the scalp
- Goosebumps
- Chills
- Urinary urgency, frequency or trouble emptying the bladder
- High blood pressure when lying down or sitting
- Rash
- Urinary urgency, frequency or retention
When to get medical help
- Call your doctor if you have a pounding headache, blurred vision or a feeling of pressure in the head, which can signal very high blood pressure when lying down.
- Get medical help if you have signs of stroke or other serious blood pressure problems, since uncontrolled high blood pressure raises the risk of stroke.
- Call your doctor if you have trouble passing urine.
- Tell your prescriber if you feel no real improvement in your symptoms, because treatment should continue only if it is helping.
- Seek urgent help after a suspected overdose.
Less often, people had headache, a feeling of pressure in the head, facial flushing, confusion, dry mouth or nervousness. Call your doctor about severe high blood pressure signs or trouble urinating.
Midodrine warnings and precautions
▾
- Supine hypertension is the biggest risk. It can raise the risk of cardiovascular events, particularly stroke.
- Blood pressure should be monitored lying down and sitting.
- Use is not recommended if lying-down systolic pressure is above 180 mmHg.
- Treatment should be stopped if lying-down pressure rises too much.
- The benefit in daily activities has not been established, so continue only if symptoms clearly improve.
Midodrine interactions
▾
Several medicines can raise blood pressure further or change midodrine's effects.
- Phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones and droxidopa add to the rise in blood pressure.
- Cardiac glycosides such as digoxin may cause a slow heart rate, heart block or arrhythmia.
- MAO inhibitors and linezolid should be avoided.
- Fludrocortisone may increase lying-down blood pressure, so it needs careful monitoring.
- Prazosin, terazosin and doxazosin can block midodrine's effects.
Interactions listed in the FDA-approved label
From the Midodrine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Cardiac glycosides: May enhance or precipitate bradycardia, A.V. block or arrhythmia.
- Drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, droxidopa): The risk of hypertension increases with concomitant administration. Avoid concomitant use; if it cannot be avoided, monitor blood pressure closely.
- Salt-retaining steroid therapy (fludrocortisone acetate): Has been used concomitantly, with or without salt supplementation; potential for supine hypertension. Carefully monitor for supine hypertension; it may be minimized by reducing the fludrocortisone acetate dose or decreasing salt intake prior to initiation of midodrine.
- Alpha-adrenergic blocking agents (prazosin, terazosin, doxazosin): Can antagonize the effects of midodrine hydrochloride tablets.
Read the label’s full interactions text
Drug Interactions When administered concomitantly with midodrine hydrochloride tablets, cardiac glycosides may enhance or precipitate bradycardia, A.V. block or arrhythmia. The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). Avoid concomitant use of drugs that increase blood pressure. If concomitant use cannot be avoided, monitor blood pressure closely. Avoid use of MAO inhibitors or linezolid with midodrine. Midodrine hydrochloride tablets have been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. The potential for supine hypertension should be carefully monitored in these patients and may be minimized by either reducing the dose of fludrocortisone acetate or decreasing the salt intake prior to initiation of treatment with midodrine hydrochloride tablets. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride tablets.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Midodrine
▾
- Do not use with severe organic heart disease, acute kidney disease, urinary retention, pheochromocytoma or thyrotoxicosis.
- Do not use with persistent, excessive high blood pressure when lying down.
- With abnormal kidney function, treatment starts at a low dose and proceeds cautiously.
- Dosing in children has not been adequately studied.
- No dose changes are suggested based on age 65 or older or on sex.
Midodrine overdose
▾
Overdose symptoms can include high blood pressure, goosebumps, a feeling of coldness and urinary retention. Reported cases also involved a slow heart rate and drowsiness or unresponsiveness. Treatment is supportive, and may include stomach emptying and medicines that block alpha receptors. Seek emergency help right away.
What Midodrine does in the body
▾
Midodrine raises standing, sitting and lying blood pressure. Standing systolic pressure rises about 15 to 30 mmHg an hour after a 10 mg dose, with some effect lasting 2 to 3 hours. It has no clinically significant effect on pulse rate in people with autonomic failure.
How your body processes Midodrine
▾
Midodrine is absorbed quickly and converted to its active form, desglymidodrine. Midodrine peaks in about half an hour. The active form peaks in 1 to 2 hours and has a half-life of about 3 to 4 hours. Food does not affect it. It is cleared mainly by the kidneys, and it is removed by dialysis.
How to store Midodrine
▾
Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) . Dispense in a tight, light-resistant container .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Midodrine
17 supplements and herbal products have documented interactions with Midodrine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 7
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Midodrine: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Midodrine — the kind of thing our pharmacy team would talk through with you at the counter.
What is midodrine for?
▾
When should I take it during the day?
▾
What side effects are normal?
▾
Why does my blood pressure need to be checked lying down?
▾
Can I take it with cold medicines or other prescriptions?
▾
Is Midodrine available over the counter?
▾
When was Midodrine first available?
▾
Who makes Midodrine?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Midodrine on HelloPharmacist
Midodrine forms and strengths (how it comes)
Midodrine is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Midodrine Hydrochloride tablets are used to treat symptomatic orthostatic hypotension.
- Midodrine HCl tablets are used for symptomatic orthostatic hypotension in people impaired despite standard care.
- Midodrine Hydrochloride tablets are taken by mouth during daytime hours when you need to be upright.
- Midodrine HCl tablets should not be given after the evening meal or less than 4 hours before bedtime.
- Midodrine Hydrochloride tablets are continued only if symptoms improve significantly, with regular blood pressure monitoring.
Midodrine on the U.S. market: products, makers and brands
How Midodrine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
32 companies list 109 Midodrine product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1996. Brand names on the directory include Orvaten, Proamatine; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (14) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Midodrine is used (Medicaid data)
A general measure of how commonly Midodrine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Midodrine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Midodrine prescribed? Of the 1,601 medications we measure, Midodrine ranks #313 by Medicaid prescriptions — more than 80% of them.
Utilization by Midodrine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
midodrine hydrochloride 5 MG Oral Tablet Most dispensed
Summed across the 20 of 68 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 993470
midodrine hydrochloride 10 MG Oral Tablet
Summed across the 14 of 55 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 993462
midodrine hydrochloride 2.5 MG Oral Tablet
Summed across the 12 of 56 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 993466
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Midodrine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 46 of 179 listed Midodrine NDCs with Medicaid activity.
Compare Midodrine products
A representative set of FDA-listed product records for Midodrine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 2.5 mg | Oral | Advagen Pharma Limited | ANDA | View NDC → |
| 5 mg | Oral | Advagen Pharma Limited | ANDA | View NDC → |
| 10 mg | Oral | Advagen Pharma Limited | ANDA | View NDC → |
| 2.5 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 5 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 5 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 10 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 2.5 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 5 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 10 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 2.5 mg | Oral | Apotex Corp | ANDA | View NDC → |
| 5 mg | Oral | Apotex Corp | ANDA | View NDC → |
| 10 mg | Oral | Apotex Corp | ANDA | View NDC → |
| 2.5 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 5 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 10 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 2.5 mg | Oral | Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 5 mg | Oral | Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | AvKARE | ANDA | View NDC → |
| 5 mg | Oral | AvKARE | ANDA | View NDC → |
| 10 mg | Oral | AvKARE | ANDA | View NDC → |
| 2.5 mg | Oral | AvPAK | ANDA | View NDC → |
| 5 mg | Oral | AvPAK | ANDA | View NDC → |
| 10 mg | Oral | AvPAK | ANDA | View NDC → |
| 2.5 mg | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 5 mg | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 10 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Cardinal Health 107, LLC × 3 listings | ANDA | View NDC → |
| 10 mg | Oral | Cardinal Health 107, LLC | ANDA | View NDC → |
| 5 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | First Nation Group, LLC | ANDA | View NDC → |
| 5 mg | Oral | First Nation Group, LLC | ANDA | View NDC → |
| 10 mg | Oral | First Nation Group, LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | Lifestar Pharma LLC | ANDA | View NDC → |
| 5 mg | Oral | Lifestar Pharma LLC | ANDA | View NDC → |
| 10 mg | Oral | Lifestar Pharma LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Major Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Major Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | Major Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Mylan Institutional Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 5 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 5 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 10 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 2.5 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 2.5 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 5 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 5 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 10 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 10 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 2.5 mg | Oral | Novugen Pharma (USA) LLC | ANDA | View NDC → |
| 5 mg | Oral | Novugen Pharma (USA) LLC | ANDA | View NDC → |
| 10 mg | Oral | Novugen Pharma (USA) LLC | ANDA | View NDC → |
| 2.5 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 5 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 10 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2.5 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 5 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 10 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 2.5 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Safecor Health LLC | ANDA | View NDC → |
| 2.5 mg | Oral | TruPharma, LLC | ANDA | View NDC → |
| 5 mg | Oral | TruPharma, LLC | ANDA | View NDC → |
| 10 mg | Oral | TruPharma, LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Umasuto, LLC | ANDA | View NDC → |
| 5 mg | Oral | Umasuto, LLC | ANDA | View NDC → |
| 10 mg | Oral | Umasuto, LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Upsher-Smith laboratories, LLC | ANDA | View NDC → |
| 5 mg | Oral | Upsher-Smith laboratories, LLC | ANDA | View NDC → |
| 10 mg | Oral | Upsher-Smith laboratories, LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Xiromed, LLC | ANDA | View NDC → |
| 5 mg | Oral | Xiromed, LLC | ANDA | View NDC → |
| 10 mg | Oral | Xiromed, LLC | ANDA | View NDC → |
| 2.5 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 5 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 10 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 2.5 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 5 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 10 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
Showing 109 of 109 products — FDA National Drug Code Directory. See every product, package size and price: browse all 109 Midodrine NDCs →
Midodrine side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Midodrine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Midodrine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Midodrine FDA approval history
How Midodrine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Midodrine recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Midodrine recall since July 2021. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. Lots: Lot # N02640, Exp Date: 08/2027 FDA record D-0383-2026 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 6963 1 dose form · 3 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 372925In current FDA listingsClinical drug / strength (SCD) hydrochloride 10 MGRxCUI 993462hydrochloride 2.5 MGRxCUI 993466hydrochloride 5 MGRxCUI 993470
Look up RxCUI 6963 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Midodrine supply and shortage status
Whether Midodrine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Midodrine costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 5 mg | $0.111 per tablet | NDC details & price history |
| Tablet · Oral | 2.5 mg | $0.074 per tablet | NDC details & price history |
| Tablet · Oral | 10 mg | $0.151 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Midodrine brand names
Midodrine is sold under 2 brand names in the FDA directory — Orvaten, Proamatine. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Midodrine: manufacturers and labelers
32 companies list Midodrine products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Major Pharmaceuticals, NorthStar Rx LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 8 more on the FDA NDC directory.
Midodrine drug class (RxNorm)
Midodrine belongs to the alpha-Adrenergic Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Midodrine page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Mylan Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →